PSMA ligands are most labeled either with 68Ga or 18F. 68Ga-PSMA, initially utilized in metastatic prostate cancer imaging, is rapidly excreted in the urine and may obscure the prostate when evaluating localized disease. This evidence concerns the gene FOLH1 and metastatic prostate carcinoma.